EU approval

CAMBRIDGE, UK, March 16, 2026 AstraZeneca has received European Commission approval for Imfinzi (durvalumab) as the first and only...

SAINT-HERBLAIN, FRANCE — November 26, 2025. Valneva has announced positive final Phase 2 results for its Lyme disease vaccine...

TARRYTOWN, N.Y. & PARIS — November 25, 2025. The European Commission has granted landmark approval for Dupixent® (dupilumab) as...